Australia markets open in 46 minutes

Guardion Health Sciences, Inc. (GHSI)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
7.90-0.10 (-1.25%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 10.17M
Enterprise value 4.77M
Trailing P/E 66.00
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.82
Price/book (mrq)1.25
Enterprise value/revenue 0.39
Enterprise value/EBITDA -1.22

Trading information

Stock price history

Beta (5Y monthly) 0.88
52-week change 341.68%
S&P500 52-week change 324.19%
52-week high 310.75
52-week low 35.01
50-day moving average 38.37
200-day moving average 37.14

Share statistics

Avg vol (3-month) 3220.03k
Avg vol (10-day) 34.01k
Shares outstanding 51.28M
Implied shares outstanding 61.28M
Float 81.05M
% held by insiders 119.83%
% held by institutions 117.50%
Shares short (15 Apr 2024) 4148.23k
Short ratio (15 Apr 2024) 46.11
Short % of float (15 Apr 2024) 417.04%
Short % of shares outstanding (15 Apr 2024) 411.54%
Shares short (prior month 15 Mar 2024) 4122.42k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:50
Last split date 309 Jan 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 1.29%
Operating margin (ttm)-23.58%

Management effectiveness

Return on assets (ttm)-14.66%
Return on equity (ttm)1.48%

Income statement

Revenue (ttm)12.25M
Revenue per share (ttm)9.64
Quarterly revenue growth (yoy)7.70%
Gross profit (ttm)N/A
EBITDA -3.92M
Net income avi to common (ttm)158.03k
Diluted EPS (ttm)0.12
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)6.36M
Total cash per share (mrq)4.95
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)9.01
Book value per share (mrq)6.39

Cash flow statement

Operating cash flow (ttm)-4.37M
Levered free cash flow (ttm)331.92k